|
Variable
|
Frequency (N)
|
Percentage (%)
|
|---|
|
Sex
|
|
Male
|
323
|
51.8
|
|
Female
|
301
|
48.2
|
|
Place of birth
|
|
Health facility
|
525
|
84.1
|
|
Home
|
55
|
8.8
|
|
Unknown
|
44
|
7.1
|
|
Type of infant feeding
|
|
Exclusive breast feeding
|
494
|
79.2
|
|
Exclusive complementary feeding
|
91
|
14.6
|
|
Mixed feeding
|
29
|
4.7
|
|
Weaned of breast feeding
|
2
|
0.3
|
|
Mothers CD4 during ANC
a
|
|
Less than 100
|
15
|
2.4
|
|
101–300
|
73
|
11.7
|
|
301–500
|
124
|
19.9
|
|
More than 500
|
182
|
29.2
|
|
Mother clinical stage during ANC
|
|
WHO stage 1
|
224
|
35.9
|
|
WHO stage 2
|
104
|
16.7
|
|
WHO stage 3
|
100
|
16
|
|
WHO stage 4
|
9
|
1.4
|
|
Undocumented
|
187
|
70
|
|
PMTCT intervention in the mother
|
|
None/unknown
|
279
|
44.7
|
|
Yes
|
345
|
55.3
|
|
Type of PMTCT intervention (mother)
|
|
AZTb only
|
50
|
8
|
|
HAARTc
|
295
|
47.3
|
|
None
|
105
|
16.8
|
|
Missing
|
174
|
27.9
|
|
Infant PMTCT intervention
|
|
Sd NVPd
|
26
|
4.2
|
|
Sd NVP + AZT
|
279
|
44.7
|
|
NVP for 6 weeks
|
179
|
28.7
|
|
NVP >6 weeks
|
12
|
1.9
|
|
None
|
90
|
14.4
|
|
Missing
|
38
|
6.1
|
|
Mother ANC
|
|
Yes
|
86
|
13.8
|
|
No
|
388
|
62.2
|
|
Missing
|
150
|
24
|
-
aAntenatal care
-
bZidovudine
-
cHighly active antiretroviral therapy
-
dNevirapine
